Skip to content

Evaluation of Education for Gestational Diabetes

Evaluation of Knowledge Regarding Gestational Diabetes and Evaluation of (Group) Education for Gestational Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02528162
Enrollment
200
Registered
2015-08-19
Start date
2015-10-31
Completion date
2019-06-30
Last updated
2020-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes

Keywords

gestational diabetes, education

Brief summary

Prospective observational cohort study of women with gestational diabetes (GDM) based on the 'International Association of Pregnancy Study Groups' (IADPSG) criteria. The overall aim is to evaluate the knowledge regarding GDM of women with GDM and to evaluate the satisfaction of women with GDM about the education they receive (given in group or individually). Normal routine care is followed and evaluated.

Interventions

BEHAVIORALeducation

Evaluation of education for GDM

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Women ≥ 18 years diagnosed with GDM in the university hospital Leuven.

Exclusion criteria

* Women who received bariatric surgery. * Women with pregestational diabetes or diagnosed with diabetes during early pregnancy.

Design outcomes

Primary

MeasureTime frame
Evaluation of the knowledge regarding GDM with a self-designed questionnaireover a 2-4 week period
Scale (0 to 3) with questionnaire on depression (CES-D )over a 2-4 week period
Evaluation of satisfaction with education and Diabetes Treatment Satisfaction Questionnaireover a 2-4 week period
Scale (1-4) with questionnaire on anxiety (six-item short form STAI)over a 2-4 week period

Secondary

MeasureTime frame
The prevalence of GDM based on the IADPSG criteriaat 24-28 weeks of pregnancy
The frequency of an HbA1c ≥6.5%at 24-28 weeks of pregnancy
Composite endpoint of glycaemic control, weight, gestational weight gain and pregnancy outcomesover a period of 16 weeks
The frequency of insulin therapy for GDMover a period of 16 weeks
The time between the glucose challenge test and oral glucose tolerance testat 24-28 weeks of pregnancy

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026